EFFICACY AND SAFETY OF 8-WEEK GLECAPREVIR/PIBRENTASVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1, 2, 3, 4, 5, OR 6 INFECTION AND COMPENSATED CIRRHOSIS: EXPEDITION-8 COMPLETE RESULTS

HEPATOLOGY(2019)

引用 0|浏览38
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要